СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Formiga Rodrigo de Oliveira, Pesenti Lucie, de la Héronnière François Chable, Ladjemi Maha Zohra, Stojkov Darko, Yousefi Shida, Frachet Philippe, Krafft Lisa, Tiberio Laura, Bosisio Daniela, Andrieu Muriel, Many Souganya, Karunanithy Vaarany, Bailly Karine, Dhôte Théo, Saraceni-Tasso Giovanni, Castel Manon, Rousseau Christophe, Starick Marick Rodrigues, da Rocha Edroaldo Lummertz, Lombardi Emilia Puig, Almeida Cicero José Luíz Dos Ramos, Ramos Anderson Dos Santos, Cunha Fernando Queiroz, Alves-Filho José Carlos, Nóbrega Natália Ribeiro Cabacinha, Gonçalves Matheus Rodrigues, Queiroz-Junior Celso Martins, Lima Batista Viviane, Teixeira Mauro Martins, Granger Vanessa, Chollet-Martin Sylvie, Chaisemartin Luc De, Mouthon Luc, Hosmalin Anne, Hurtado-Nedelec Margarita, Martin Clémence, Spiller Fernando, Simon Hans-Uwe, Tamassia Nicolas, Cassatella Marco Antonio, Pène Frédéric, Vogl Thomas, Burgel Pierre-Regis, Costa Vivian Vasconcelos, Witko-Sarsat Véronique
Аннотация
Neutrophils are central mediators of the hyperinflammatory response in severe SARS-CoV-2 infection. We report elevated cytosolic levels of proliferating cell nuclear antigen (PCNA) in neutrophils from patients with severe and critical COVID-19, correlating with enhanced NADPH oxidase-dependent reactive oxygen species (ROS) generation and neutrophil extracellular trap (NET) formation. Using T2AA, a small-molecule inhibitor of the PCNA scaffold, we demonstrate potent suppression of NADPH oxidase activation and NET release, particularly in response to SARS-CoV-2 RNA. Mechanistically, we identify a previously unrecognized interaction between PCNA and the heterodimeric S100A8/S100A9 (calprotectin), predominantly enriched in CD16highCD62Llow neutrophils expanded during COVID-19. PCNA binds the dimeric S100A8/S100A9 complex mediated via S100A8 subunit with micromolar affinity, and this interaction is abrogated by tetramerization, suggesting regulation by intracellular calcium. Disruption of this complex by T2AA inhibited ROS production in an S100A8/S100A9-dependent manner, implicating calprotectin as a functional regulator of neutrophil activation. In a betacoronavirus mouse model, T2AA treatment attenuated lung inflammation, reduced NET and calprotectin levels, and shifted pulmonary neutrophils away from hyperactivated and immunosuppressive phenotypes, consistent with immune reprogramming toward resolution. These findings establish cytosolic PCNA as a central scaffold in neutrophil hyperactivation during COVID-19 and highlight its pharmacological disruption as a promising host-directed strategy to limit inflammation and prevent organ damage.